AnaptysBio Stock Price - ANAB

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
AnaptysBio Inc ANAB NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 18.67 0.00 0.00 0.00 18.67 20:00:00
Bid Price Ask Price Spread Spread % News
18.30 19.50 1.20 6.15% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 18.67 USD

AnaptysBio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 509.26M 27.28M 26.79M $ 8.00M $ - -3.61 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 9.00 1.80%

more financials information »

AnaptysBio News

Date Time Source News Article
5/06/202016:15Edgar (US Regulatory)Quarterly Report (10-q)
5/06/202016:12Edgar (US Regulatory)Current Report Filing (8-k)
5/06/202016:05GlobeNewswire Inc.AnaptysBio Announces First Quarter 2020 Financial Results..
4/29/202019:26Business WireShareholder Alert: Robbins LLP Announces It Is Investigating..
4/27/202016:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)
4/27/202016:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)
4/09/202014:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ANAB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.1021.3118.0019.31432,279-0.43-2.25%
1 Month17.8421.3117.567919.32352,9290.834.65%
3 Months14.4521.3112.0615.90458,5404.2229.2%
6 Months14.5121.3111.9515.70518,0664.1628.67%
1 Year74.0377.2859.1621.59544,424-55.36-74.78%
3 Years24.95134.009.1651.11395,484-6.28-25.17%
5 Years16.00134.009.1650.15366,1882.6716.69%

AnaptysBio Description

AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200605 07:34:53